ArticleFrontiers in oncology2025
Evaluation of the diagnostic value of magnetic resonance imaging combined with ultrasound and mammography for breast cancer using array spatial sensitivity encoding technique.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MMBCFNet: multi modal hybrid deep learning framework for breast cancer detection using MRI, mammography, and ultrasound images.Journal of ultrasound · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the diagnostic efficacy of magnetic resonance imaging (MRI) combined with ultrasound and mammography for breast cancer (BC) using array spatial sensitivity encoding technique (ASSET). Methods: MRI images are processed using parallel imaging (PI) and ASSET techniques. The signal-to-noise ratio (SNR) of ASSET-diffusion-weighted imaging (DWI) and PI-DWI, as well as the contrast-to-noise ratio (CNR) between lesions and normal breast tissue, were compared. Image quality was also assessed. Using 70 cases of BC as the observation group (OG) and 70 non-BC cases as the control group (CG), the imaging characteristics of MRI, ultrasound, and mammography in both groups were compared. The Accuracy ( Results: Relative to the PI-DWI sequence, the ASSET-DWI sequence demonstrated notably shorter scanning time, higher CNR between lesions and normal breast tissue, better lesion visualization, clearer lesion margins, fewer image artifacts, and higher overall image quality ( Conclusion: The combined use of MRI, ultrasound, and mammography based on ASSET for BC diagnosis offers significant advantages, providing clinicians with more reliable diagnostic tools.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.